There's a study that was just published and this was out of Bangladesh.

Now, it has to do with the Pentavalent vaccine.

That's a five-in-one vaccine.

It's basically DTP, HBV, and HIB.

It's all in one.

In 2020, UNICEF and the WHO issue guidelines for developing nations on a Penta vaccine.

And a year later, that vaccine accounted for 100% of the DTP containing vaccines that

UNICEF uses.

As far as developing nations, these children are all getting this vaccine.

So the study, it's called Penta, is associated with an increased female male mortality

ratio.

That's not a Bangladesh.

So the examin mortality rates of over 7,000 children from 2011 to 2016.

The conclusion on the study reads, quote,

Penta, as the most recent administered vaccination, was associated with significant

excess female mortality between six weeks and nine months of age.

And that's the window when they get this Penta vaccine.

So they found that girls had higher mortality than boys at the age of the Penta vaccination,

which is two to nine months.

And this is in partnership with the Guinea-Bassao and Peter Abe's group.

And they're findings basically consistent with several other findings with the DTP vaccine

when it comes to mortality, specifically female mortality.

...